SCHEMBL3753495

SCHEMBL3753495

N=C(N)NCCCC(NC(=O)C(N)CCC(N)=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 4/20 0.46
▸ NPY4R P50391 11/20 0.44
▸ NPY1R P25929 6/20 0.44
▸ NPY2R P49146 4/20 0.44
▸ NPY5R Q15761 4/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ DPP4 P27487 1/20 0.43
▸ DPP8 Q6V1X1 1/20 0.43
▸ DPP9 Q86TI2 1/20 0.43
▸ FNTA P49354 2/20 0.38
▸ FNTB P49356 2/20 0.38
▸ PGGT1B P53609 1/20 0.38
▸ FOLH1 Q04609 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753503 1.00 NOD1 (0.46) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL9189359 1.00 NOD1 (0.46) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29794145 0.97 NPY4R (0.47) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29779796 0.97 NPY4R (0.47) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL268800 0.95 NPY4R (0.44) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL268799 0.95 NPY4R (0.44) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL269045 0.95 NPY4R (0.44) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30249102 0.95 NPY4R (0.44) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30587027 0.94 NPY4R (0.43) NOD1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29887603 0.94 NPY4R (0.48) NOD1NPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0457314-A1 Nutrient compositions containing peptides CLINTEC NUTRITION COMPANY (US) 1991-11-21 — — EP claimed
US-7833524-B2 Method of preparing botulinum neurotoxin type E light chain WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-11-16 — — US disclosed
US-20090182123-A1 Method of Preparing Botulinum Neurotoxin Type E Light Chain NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-07-16 — — US disclosed
US-7465457-B2 Method for preparing botulinum neurotoxin type A light chain WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-12-16 — — US disclosed
US-20060258847-A1 Method of preparing botulinum neurotoxin type A light chain NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-11-16 — — US disclosed
US-20060217321-A1 Compositions to improve tic disorders TAIYOKAGAKU CO., LTD. (JP) 2006-09-28 — — US disclosed
US-5965699-A SUBSTRATE PEPTIDE MODIFIED BY ACETYLATING N-TERMINAL AND ELIMINATING NEGATIVE CHARGE AT C-TERMINAL; FOR RAPID DETECTION WITHOUT SEPARATING PRODUCTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1999-10-12 — — US disclosed
Send feedback